PERKINS CAPITAL MANAGEMENT INC

Position in CDXS — Codexis, Inc.

CIK 884300 WAYZATA, MN

Position in CDXS

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$1,188,986

+$329,161 QoQ

Shares Held

526,100

-0.3% QoQ

Ownership

0.579%

of shares outstanding

% of Portfolio

0.94%

of 13F equity value

Holder Rank

of 31 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 92% Shared 0% None 8%

Healthcare · as of Jun 30, 2026

PERKINS CAPITAL MANAGEMENT INC holds $2,091,815 across 5 Biotechnology names. CDXS ranks #1 (56.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CDXS	Codexis, Inc. This page	526,100	$1,188,986
2	CELC	Celcuity Inc.	4,500	$470,790
3	MRNA	Moderna, Inc.	4,000	$280,120
4	PBYI	Puma Biotechnology, Inc.	13,400	$108,674
5	DYAI	Dyadic International Inc	48,050	$43,245

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,188,986	526,100	-0.3%	Shares	Sole	2026-07-24
2026-03-31	$859,825	527,500	-0.4%	Shares	Sole	2026-04-23
2025-12-31	$863,085	529,500	+72.1%	Shares	Sole	2026-02-04
2025-09-30	$750,788	307,700	-1.4%	Shares	Sole	2025-10-31
2025-06-30	$761,280	312,000	-2.1%	Shares	Sole	2025-08-07
2025-03-31	$857,572	318,800	+69.3%	Shares	Sole	2025-05-07
2024-12-31	$898,429	188,350	+14.8%	Shares	Sole	2025-02-11
2024-09-30	$505,428	164,100	+2.8%	Shares	Sole	2024-10-31
2024-06-30	$495	159,600	0.0%	Shares	Sole	2024-08-09
2024-03-31	$557	159,600	+242.5%	Shares	Sole	2024-05-09
2023-12-31	$142	46,600	+106.2%	Shares	Sole	2024-01-22
2023-09-30	$43	22,600	—	Shares	Sole	2023-11-02
No filing history on record for this holder in this stock.